However, the high level of Gli in pancreatic ductal adenocarcinoma cells (PDACs) seems adverse to their migration [66], indicating that targeting MLN4924 in PSCs and PDACs probably has opposing effects on cancer progression. This evidence concerns the gene GLI1 and cancer.